Cargando…
Cost of epilepsy-related health care encounters in the United States
BACKGROUND: The cost of epilepsy is usually reported as total expenditure over a certain period. However, with the increased availability of acute treatments for use in the community setting, intermittent, single-seizure treatment is now possible in addition to the chronic epilepsy drug treatment pa...
Autores principales: | Borghs, Simon, Beaty, Silky, Parekh, Witesh, Kalilani, Linda, Boudiaf, Nada, Loewendorf, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390911/ https://www.ncbi.nlm.nih.gov/pubmed/33103619 http://dx.doi.org/10.18553/jmcp.2020.20111 |
Ejemplares similares
-
The characteristics and treatment patterns of patients with Parkinson’s disease in the United States and United Kingdom: A retrospective cohort study
por: Kalilani, Linda, et al.
Publicado: (2019) -
Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort
por: Pollock, Carol, et al.
Publicado: (2022) -
Cost analysis of insulin degludec in comparison with insulin detemir in treatment of children and adolescents with type 1 diabetes in the UK
por: Thalange, Nandu, et al.
Publicado: (2019) -
Clinical and Economic Outcomes of Intravenous Brivaracetam Compared With Levetiracetam for the Treatment of Seizures in United States Hospitals
por: Beaty, Silky, et al.
Publicado: (2021) -
Retrospective cohort analysis of healthcare claims in the United States characterising asthma exacerbations in paediatric patients
por: Suruki, Robert Y., et al.
Publicado: (2016)